首页> 外文期刊>APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica >Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability
【24h】

Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability

机译:微卫星不稳定性胃癌和大肠癌中SMC2基因的突变和表达分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Structural maintenance of chromosomes 2 (SMC2) gene encodes condensin complexes that are required for proper chromosome segregation and maintenance of chromosomal stability. Although cells with defective chromosome segregation become aneuploid and are prone to harbor chromosome instability, pathologic implications of SMC2 gene alterations are largely unknown. In a public database, we found that SMC2 gene had mononucleotide repeats that could be mutated in cancers with microsatellite instability (MSI). In this study, we analyzed these repeats in 32 gastric cancers (GC) with high MSI (MSI-H), 59 GC with low MSI (MSI-L)/stable MSI (MSS), 43 colorectal cancers (CRC) with MSI-H and 60 CRC with MSI-L/MSS by single-strand conformation polymorphism (SSCP) and DNA sequencing. We also analyzed SMC2 protein expression in GC and CRC tissues using immunohistochemistry. We found SMC2 frameshift mutations in two GC and two CRC that would result in truncation of SMC2. The mutations were detected exclusively in MSI-H cancers, but not in MSI-L/MSS cancers. Loss of SMC2 expression was observed in 22% of GC and 25% of CRC. Of note, all of the cancers with SMC2 frameshift mutations displayed loss of SMC2 expression. Also, both GC and CRC with MSI-H had significantly higher incidences in SMC2 frameshift mutations and loss of SMC2 expression than those with MSI-L/MSS. Our data indicate that SMC2 gene is altered by both frameshift mutation and loss of expression in GC and CRC with MSI-H, and suggest that SMC2 gene alterations might be involved in pathogenesis of these cancers.
机译:染色体2(SMC2)基因的结构维持编码正确的染色体分离和维持染色体稳定性所需的凝凝素复合物。尽管具有缺陷性染色体分离的细胞会变成非整倍体,并容易出现染色体不稳定性,但SMC2基因改变的病理学意义尚不清楚。在一个公共数据库中,我们发现SMC2基因具有单核苷酸重复序列,在具有微卫星不稳定性(MSI)的癌症中可能发生突变。在这项研究中,我们分析了32种MSI高(MSI-H)胃癌(GC),59 MSI低(MSI-L)/稳定MSI(MSS)的GC,43种MSI-MS大肠癌(CRC)的重复序列。通过单链构象多态性(SSCP)和DNA测序,将H和60 CRC与MSI-L / MSS结合使用。我们还使用免疫组织化学分析了GC和CRC组织中SMC2蛋白的表达。我们在两个GC和两个CRC中发现SMC2移码突变会导致SMC2的截短。仅在MSI-H癌症中检测到突变,而在MSI-L / MSS癌症中未检测到。在22%的GC和25%的CRC中观察到SMC2表达缺失。值得注意的是,所有具有SMC2移码突变的癌症均显示SMC2表达缺失。同样,与MSI-L / MSS相比,MSI-H的GC和CRC在SMC2移码突变和SMC2表达损失方面的发生率显着更高。我们的数据表明,SMC2基因被移码突变和MSI-H在GC和CRC中的表达缺失所改变,并暗示SMC2基因的改变可能与这些癌症的发病机制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号